Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950133-07-000648
Filing Date
2007-02-16
Accepted
2007-02-16 14:30:14
Documents
2
Group Members
VENROCK ASSOCIATES II, L.P.

Document Format Files

Seq Description Document Type Size
1 ICAGEN, INC. SCHEDULE 13D w30537sc13d.htm SC 13D 75646
2 EX-A w30537exv99wa.htm EX-99.A 5871
  Complete submission text file 0000950133-07-000648.txt   83342
Mailing Address
Business Address 4222 EMPEROR BLVD SUITE 350 DURHAM NC 27703 919-941-5206
ICAGEN INC (Subject) CIK: 0000902622 (see all company filings)

EIN.: 561785001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81358 | Film No.: 07630736
SIC: 2834 Pharmaceutical Preparations

Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Filed by) CIK: 0000937889 (see all company filings)

EIN.: 136300995 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D